Provided by Tiger Trade Technology Pte. Ltd.

TELA Bio, Inc.

0.6229
-0.0234-3.62%
Volume:32.65K
Turnover:21.02K
Market Cap:27.88M
PE:-0.80
High:0.6561
Open:0.6561
Low:0.6229
Close:0.6463
52wk High:2.00
52wk Low:0.5011
Shares:44.77M
Float Shares:21.52M
Volume Ratio:0.61
T/O Rate:0.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7776
EPS(LYR):-0.8300
ROE:-616.62%
ROA:-33.40%
PB:-1.76
PE(LYR):-0.75

Loading ...

TELA Bio CEO Heather Getz Acquires 12,500 Common Shares Valued at $8,311.25

Reuters
·
Aug 20

TELA Bio CEO Makes Bold Move Signaling Fresh Confidence in the Company

TIPRANKS
·
Aug 18

TELA Bio CEO Heather C. Getz Acquires Common Shares Worth $10,467

Reuters
·
Aug 18

Tenon Medical Q2 Revenue Jumps on Higher Surgical Procedure Volume

Reuters
·
Aug 14

TELA Bio Amends 8-K to Detail Former CEO Koblish Separation Benefits

Reuters
·
Aug 14

Sanara MedTech Q2 Revenue Rises on Soft-Tissue Product Growth

Reuters
·
Aug 12

Analysts Conflicted on These Healthcare Names: Rocket Pharmaceuticals (RCKT), Sonida Senior Living (SNDA) and TELA Bio (TELA)

TIPRANKS
·
Aug 11

Xtant Medical Q2 Revenue Falls on Asset Sales and Lost License Revenue

Reuters
·
Aug 11

Piper Sandler Sticks to Its Hold Rating for TELA Bio (TELA)

TIPRANKS
·
Aug 11

TELA Bio Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11

TELA Bio Q2 Revenue Falls on Lower OviTex PRS Volumes, Withdraws Outlook

Reuters
·
Aug 11

TELA Bio Q2 FY26 Net Loss Widens to $11.3 Million; Revenue Drops 4% to $19.3 Million

Reuters
·
Aug 11

TELA Bio Q2 EPS $(0.20) Misses $(0.18) Estimate, Sales $19.291M Miss $20.008M Estimate

Benzinga Earnings
·
Aug 11

TELA Bio Q2 Revenue USD 19.291 Million Vs. IBES Estimate USD 20 Million

Reuters
·
Aug 11

TELA Bio - Withdraws Full Year 2026 Revenue Guidance

THOMSON REUTERS
·
Aug 11

TELA Bio Q2 Basic EPS USD -0.2

THOMSON REUTERS
·
Aug 11

TELA Bio Q2 Operating Expenses USD 23.226 Million

THOMSON REUTERS
·
Aug 11

TELA Bio Reports Second Quarter 2026 Financial Results

GlobeNewswire
·
Aug 11

TELA Bio Inc Expected to Post a Loss of 18 Cents a Share - Earnings Preview

Reuters
·
Aug 08

TELA Bio CEO, Director Heather Getz Files Initial Beneficial Ownership Statement

Reuters
·
Aug 06